search
Back to results

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

Primary Purpose

Myofascial Trigger Point Pain

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Integrated Neuromuscular Inhibition Technique
Myofascial Release
Sponsored by
Superior University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Myofascial Trigger Point Pain

Eligibility Criteria

25 Years - 40 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: ● Age between 25-40 Both males and females included Participants suffering from recent cervical pain without any pathology. Exclusion Criteria: ● Participants having cervical radiculopathy Having recent trauma of the cervical spine Non-cooperative subject

Sites / Locations

  • Chaudhary Muhammad Akram Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Neuromuscular Inhibition Technique

Myofascial Release

Arm Description

Outcomes

Primary Outcome Measures

Cervical Range of Motion measurement

Secondary Outcome Measures

Full Information

First Posted
April 3, 2023
Last Updated
April 3, 2023
Sponsor
Superior University
search

1. Study Identification

Unique Protocol Identification Number
NCT05816161
Brief Title
Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction
Official Title
Comparison of The Effects of The Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction in Individuals With Nonspecific Cervical Pain
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
April 1, 2023 (Actual)
Primary Completion Date
June 1, 2023 (Anticipated)
Study Completion Date
August 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Superior University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
to findout the improvement by Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myofascial Trigger Point Pain

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Neuromuscular Inhibition Technique
Arm Type
Experimental
Arm Title
Myofascial Release
Arm Type
Other
Intervention Type
Diagnostic Test
Intervention Name(s)
Integrated Neuromuscular Inhibition Technique
Intervention Description
Exercises
Intervention Type
Diagnostic Test
Intervention Name(s)
Myofascial Release
Intervention Description
Exercises
Primary Outcome Measure Information:
Title
Cervical Range of Motion measurement
Time Frame
6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ● Age between 25-40 Both males and females included Participants suffering from recent cervical pain without any pathology. Exclusion Criteria: ● Participants having cervical radiculopathy Having recent trauma of the cervical spine Non-cooperative subject
Facility Information:
Facility Name
Chaudhary Muhammad Akram Hospital
City
Lahore
State/Province
Punjab
Country
Pakistan

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

We'll reach out to this number within 24 hrs